Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
08/29/2007 | CN101024030A Medicine for preventing bedsore |
08/29/2007 | CN101024017A Chinese medicine for treating chloasma |
08/29/2007 | CN101024001A Burn spraying medicine preparation |
08/29/2007 | CN101024000A Fangfengxiao bai-pill of Chinese ready medicine and preparing method for treating vitiligo |
08/29/2007 | CN101023993A Chloasma diminishing medicine containing deer foetus and functional food and preparing method |
08/29/2007 | CN101023985A Medicine for treating tinea mannum and tinea pedis and preparing method thereof |
08/29/2007 | CN101023984A Pregnant-woman breast-nursing oil |
08/29/2007 | CN101023959A Capsule for treating corn |
08/29/2007 | CN101023955A Medicine composition and use |
08/29/2007 | CN101023949A Loratadine dispersible tablets and its preparing method |
08/29/2007 | CN101023947A Methods and compositions for bactericide, bacteriostatic and anti-inflammation |
08/29/2007 | CN101023945A Use of non-periphery substituted phthalocyaniu metal complex |
08/29/2007 | CN101023915A Pharmaceutical agent containing birch extract as an effective ingredient and its use |
08/29/2007 | CN101023913A Dander cleaning shampoo |
08/29/2007 | CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine |
08/29/2007 | CN100333789C Gel gent of Chiense forest frog bactericidal peptide and its preparation process |
08/29/2007 | CN100333766C Medicine for treating dermatopathy and its preparing process |
08/29/2007 | CN100333760C Chinese medicine for treating trichomadesis and preparation thereof |
08/29/2007 | CN100333748C Chinese medicine composition for treating baldness and its preparing method |
08/29/2007 | CN100333744C Acne treating medicine |
08/29/2007 | CN100333740C Tincture for trenting fungus dermatosis |
08/29/2007 | CN100333739C External sterilizing Mongolian medicine lotion for skin and external genital organs |
08/29/2007 | CN100333737C Medicine for beautifying face |
08/29/2007 | CN100333709C Antioxidant, skin preparation for external use, cosmetic and food |
08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
08/28/2007 | US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
08/28/2007 | US7262180 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
08/28/2007 | US7262062 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
08/28/2007 | US7261910 Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use |
08/28/2007 | CA2405072C Gel compositions containing metronidazole |
08/28/2007 | CA2264693C Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
08/28/2007 | CA2257875C Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
08/28/2007 | CA2218619C Antibacterial-wound healing compositions and methods for preparing and using same |
08/23/2007 | WO2007094776A1 Compositions and methods for suppressing fibrocyte differentiation |
08/23/2007 | WO2007094669A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
08/23/2007 | WO2007094605A1 Topical preparation composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases |
08/23/2007 | WO2007094601A1 Extract of stewartia koreana and use thereof |
08/23/2007 | WO2007094413A1 Medicinal composition for transdermal administration |
08/23/2007 | WO2007094384A1 External preparation for skin containing flavanone derivative |
08/23/2007 | WO2007094312A1 Agent for promoting vitamin c transporter production |
08/23/2007 | WO2007094200A1 Skin-whitening cosmetic |
08/23/2007 | WO2007094193A1 Anti-angiogenic agent, prophylactic or therapeutic agent for disease accompanied by angiogenesis, and food |
08/23/2007 | WO2007093839A1 New polypeptides kxk and their use |
08/23/2007 | WO2007093184A2 Treatment of mmp-mediated dermatological diseases with pemirolast |
08/23/2007 | WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
08/23/2007 | WO2007039058A3 Use of opioid receptor antagonists |
08/23/2007 | WO2007015866A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders |
08/23/2007 | WO2006097337A3 11β-HYDROXYSTEROID DEHYDROGENASES |
08/23/2007 | WO2000021486A3 Prevention of uv-induced functional vitamin a deficiency through use of topically applied retinoid |
08/23/2007 | US20070197648 Pharmaceutical product containing tranilast |
08/23/2007 | US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
08/23/2007 | US20070197570 Indanol derivative |
08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
08/23/2007 | US20070197501 Use Of Chemotherapeutic Agents |
08/23/2007 | US20070197483 External preparation for treating painful skin wound |
08/23/2007 | US20070197476 Triptolide Derivatives And Their Uses |
08/23/2007 | US20070197434 Theurapeutic or prophyiactic agent for arthritis |
08/23/2007 | US20070196460 External preparation for treating skin or mucosal injury caused by viral infection |
08/23/2007 | US20070196289 Use Of Licochalcone A Or Of An Extract Of Licochalcone A From Radix Glycyrrhizae Inflatae Against Skin Aging |
08/23/2007 | DE102006008772A1 Hydroxymatairesinol gegen trockene Haut Hydroxymatairesinol dry skin |
08/23/2007 | DE102006008771A1 Gegen unreine Haut und milde Formen der Akne wirksame Zubereitungen mit einem Gehalt an Hydroxymatairesinol als wirksames Prinzip Against blemished skin and mild forms of acne effective preparations containing hydroxymatairesinol as the active principle |
08/23/2007 | DE102006008770A1 Verwendung von Hydroxymatairesinol zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen The use of hydroxymatairesinol for the preparation of cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions |
08/23/2007 | DE102006008769A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Hydroxymatairesinol zur Hautaufhellung von Altersflecken bzw. zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung Cosmetic or dermatological preparations containing hydroxymatairesinol for skin lightening age spots or to avoid tanning of the skin, particularly caused by UV radiation tanning |
08/23/2007 | DE102006008730A1 Use of cosmetic or dermatological preparation in the form of oil-in-emulsion comprising hydroxymatairesinol for the tightening and/or strengthening of the skin, preferably for cellulite |
08/23/2007 | DE102006006905A1 Mittel zur Blutstillung Means for hemostasis |
08/23/2007 | DE102006006904A1 Neue Mittel zur Blutstillung und Klebstoffe für medizinische Anwendungen Novel agents for hemostasis and adhesives for medical applications |
08/23/2007 | DE102005062417A1 Kompositionen mit spezifischen und unspezifischen Lipidantagonisten Compositions with specific and nonspecific lipid antagonists |
08/23/2007 | CA2645734A1 Method of treating inflammatory diseases |
08/23/2007 | CA2642524A1 External preparation for skin containing flavanone derivative |
08/23/2007 | CA2641106A1 Skin-whitening cosmetic |
08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
08/22/2007 | EP1820510A1 Botulinum toxin therapy for skin disorders |
08/22/2007 | EP1820495A2 Microspheres for active embolization |
08/22/2007 | EP1819355A2 Methods of using chimeric coiled-coil molecule |
08/22/2007 | EP1592431A4 Method of modulating il-6 |
08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
08/22/2007 | EP1499320B1 Novel compounds |
08/22/2007 | EP1495075B1 Solid emulsions based on thermoplastic elastomers |
08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
08/22/2007 | EP1453804B1 Ccr-3 receptor antagonists vii |
08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
08/22/2007 | EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
08/22/2007 | EP1335700B1 Pharmaceutical composition comprising chelating/sequestering agents and their dermatological use |
08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
08/22/2007 | EP1183256B1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
08/22/2007 | EP1178952B1 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
08/22/2007 | EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
08/22/2007 | CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands |
08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
08/22/2007 | CN1332708C Chloasma treating medicine |
08/22/2007 | CN1332696C Chinese medicinal composition for treating youth pox colour spot |
08/22/2007 | CN1332694C Freckle removing medicine |
08/22/2007 | CN1332692C Drinking tea for treating dermatitis |
08/22/2007 | CN1332684C Rapid-acting hair promoting liquid |
08/22/2007 | CN1332682C Externally applied medicine for treating pityriasis simplex and its prepn. method |